menu

Quintiles Library

Show Filters
Brochure
The Executive Vision Forum is an annual event that brings together top industry experts in a small, intimate environment to discuss, debate and digest the rising trends, innovations, challenges and opportunities facing biopharma today.Hosted in New York City on November 6, the 2015 forum focused on the need to transform clinical development by incorporating the needs of...
Read More
White Paper
Pre-profiling – prospectively stratifying patients through genomic screening – was developed to provide value to patients via access to rapid, broad-based genomic testing of their cancer and to drive value to clinical study sponsors through faster recruitment of niche patient populations. Pre-profiling is a core component of Quintiles Precision Enrollment, which connects...
Explore More
Video
Dr. Nancy Dreyer, global chief of Scientific Affairs for Quintiles’ Real-World & Late Phase Research division, shares details about conducting enriched studies with prospective and retrospective data and their potential to answer more research questions.
Fact Sheet
A purely prospective approach to real-world research can result in long timelines – and still may not answer all of your questions. By integrating the wealth of existing data with primary data from physicians and patients, enriched studies for real-world research can greatly increase the amount of information available on your target population, helping you dig deeper...
Read More
Video
Quintiles' VP Peter DiBiaso discusses Project Leadership and Partnering with mid-market biopharma.
White Paper
This white paper discusses partnering solutions that are specifically tailored for emerging biopharma. Given tremendous advances in this segment of the overall biopharmaceutical market, even though each company may only have one or two assets, the total pipeline is equivalent to roughly two-thirds of the entire global industry pipeline.Emerging biopharma is well served...
Explore More
Infographic
There are many challenges facing clinical development today: study protocol complexity, costs, finding the right sites and patients, and data integration complexity are just a few. Risk-based monitoring (RBM) is becoming an industry standard in order to mitigate these risks and challenges. Partner with Quintiles, the RBM market leader, to reduce risks and costs, improve...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C.-- Quintiles Transnational Holdings Inc. (NYSE: Q) will release its fourth-quarter 2015 financial results Thursday, February 11, 2016 prior to its quarterly earnings call at 8:00 a.m. EST. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To...
Read More
Brochure
Pharmaceutical success rests on a simple principle: prove the value of your treatments, or risk losing the chance to gain market access for your product. With overall healthcare costs climbing, payers have higher expectations for a medical treatment’s proof of value before paying for it. Germany in particular has a set of very specific regulatory requirements that make...
Read More
Fact Sheet
Biosimilars studies require a cost-effective, global solution for both the efficient recruitment of healthy volunteers and for the collection of accurate data to help seamlessly transition studies from Phase I to Phase III. Quintiles has developed a comprehensive suite of services, with central oversight provided by experienced project managers, to help meet the demands...
Read More
Infographic
Today, there are increased opportunities for new biosimilars development. Hundreds of biosimilars are in development today. But the demands of biosimilars development are unique. Delivering a successful and timely early phase biosimilars study is dependent on a number of key factors. Read more about it in our latest infographic.
Read More
Fact Sheet
Quintiles’ HTA Watch is a web-based service offering instant access to a global repository of published HTA reports from nearly 100 agencies in 32 countries, providing regularly updated assessments to help inform life sciences and healthcare companies’ strategic decision-making*. In this edition of our HTA uncovered series, we will look specifically at the evaluation of...
Read More
Infographic
Development of new vaccines presents an array of challenges, including recruiting special populations, addressing fragile viral sample logistics and entering endemic geographies – often under tight timelines. To address these challenges, Quintiles’ dedicated team of vaccine experts led by the Quintiles’ Vaccines Center of Excellence (COE) provides global expertise in...
Read More
Infographic
Safety can’t wait. That’s why we’re always ready. When you partner with Quintiles, our world-class cross-functional teams will deliver comprehensive patient safety solutions across your product’s lifecycle – from clinical to late-phase to real-world. Click on our infographic to learn about Quintiles' suite of integrated, comprehensive safety services and learn the...
Read More
Infographic
The Asia Pacific Emerging Biopharma Solution provides dedicated and numble operational support combined with Quintiles' unmathced depth of expertise and breadth of perspective across the lifecycle.
Read More
Infographic
Pediatric studies require specialized expertise to ensure study design and protocol-required procedures are appropriate for children and include support for the family during the trial.  Through our Pediatric Center of Excellence, Quintiles brings together the therapeutic, regulatory and operational expertise to help you design and execute a feasible pediatric program.
Read More
Infographic
This infographic shows how Quintiles can help lower the costs associated with the ongoing maintenance of your established products while generating additional insights into your portfolio by providing a fully integrated regulatory, safety and benefit-risk management function.
Read More
Infographic
Quintiles is committed to delivering quality lab management services. The CAP ISO15189 Quality Management Program ensures robust quality systems are in place to protect the integrity of your lab samples and data. Click on our infographic to learn more about our CAP ISO15189 accreditation in our global labs.
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – December 21, 2015 – Quintiles CEO Tom Pike will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 in San Francisco at the Westin St. Francis Hotel. The Quintiles presentation will begin at 3:30 p.m. (PST).  Investors may access a live audio webcast of the presentation on the Quintiles’ investor...
Read More
Article
Since its release 10 years ago, ICH Guideline E141 has governed the clinical proarrhythmic cardiac safety regulatory landscape: it has been adopted by the United States Food and Drug Administration (FDA), Health Canada, the European Medicines Agency (EMA), and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The goal of premarketing proarrhythmic cardiac...
Explore More